Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Bioconjug Chem ; 2023 Mar 30.
Article in English | MEDLINE | ID: mdl-36996808

ABSTRACT

Targeted delivery of nucleic acid therapeutics to the lungs could transform treatment options for pulmonary disease. We have previously developed oligomeric charge-altering releasable transporters (CARTs) for in vivo mRNA transfection and demonstrated their efficacy for use in mRNA-based cancer vaccination and local immunomodulatory therapies against murine tumors. While our previously reported glycine-based CART-mRNA complexes (G-CARTs/mRNA) show selective protein expression in the spleen (mouse, >99%), here, we report a new lysine-derived CART-mRNA complex (K-CART/mRNA) that, without additives or targeting ligands, shows selective protein expression in the lungs (mouse, >90%) following systemic IV administration. We further show that by delivering siRNA using the K-CART, we can significantly decrease expression of a lung-localized reporter protein. Blood chemistry and organ pathology studies demonstrate that K-CARTs are safe and well-tolerated. We report on the new step economical, organocatalytic synthesis (two steps) of functionalized polyesters and oligo-carbonate-co-α-aminoester K-CARTs from simple amino acid and lipid-based monomers. The ability to direct protein expression selectively in the spleen or lungs by simple, modular changes to the CART structure opens fundamentally new opportunities in research and gene therapy.

2.
J Am Chem Soc ; 141(21): 8416-8421, 2019 05 29.
Article in English | MEDLINE | ID: mdl-31083999

ABSTRACT

RNA technology is transforming life science research and medicine, but many applications are limited by the accessibility, cost, efficacy, and tolerability of delivery systems. Here we report the first members of a new class of dynamic RNA delivery vectors, oligo(serine ester)-based charge-altering releasable transporters (Ser-CARTs). Composed of lipid-containing oligocarbonates and cationic oligo(serine esters), Ser-CARTs are readily prepared (one flask) by a mild ring-opening polymerization using thiourea anions and, upon simple mixing with mRNA, readily form complexes that degrade to neutral serine-based products, efficiently releasing their mRNA cargo. mRNA/Ser-CART transfection efficiencies of >95% are achieved in vitro. Intramuscular or intravenous (iv) injections of mRNA/Ser-CARTs into living mice result in in vivo expression of a luciferase reporter protein, with spleen localization observed after iv injection.


Subject(s)
Esters/chemistry , RNA, Messenger/genetics , Serine/chemistry , Thiourea/chemistry , Animals , Anions/chemistry , Esters/administration & dosage , Female , Genetic Vectors/administration & dosage , Genetic Vectors/chemistry , HeLa Cells , Humans , Luciferases/chemistry , Luciferases/metabolism , Mice , Mice, Inbred BALB C , Molecular Structure , Polymerization , RNA, Messenger/administration & dosage , RNA, Messenger/metabolism , Repressor Proteins/chemistry , Repressor Proteins/metabolism , Serine/administration & dosage , Spleen/chemistry , Spleen/metabolism
3.
Angew Chem Int Ed Engl ; 57(41): 13582-13586, 2018 10 08.
Article in English | MEDLINE | ID: mdl-30112821

ABSTRACT

RNAs are a promising class of therapeutics given their ability to regulate protein concentrations at the cellular level. Developing safe and effective strategies to deliver RNAs remains important for realizing their full clinical potential. Here, we develop lipid nanoparticle formulations that can deliver short interfering RNAs (for gene silencing) or messenger RNAs (for gene upregulation). Specifically, we study how the tail length, tail geometry, and linker spacing in diketopiperazine lipid materials influences LNP potency with siRNAs and mRNAs. Eight lipid materials are synthesized, and 16 total formulations are screened for activity in vitro; the lead material is evaluated with mRNA for in vivo use and demonstrates luciferase protein expression in the spleen. In undertaking this approach, not only do we develop synthetic routes to delivery materials, but we also reveal structural criteria that could be useful for developing next-generation delivery materials for RNA therapeutics.


Subject(s)
Lipids/chemistry , Nanoparticles/chemistry , RNA, Messenger/administration & dosage , RNA, Small Interfering/administration & dosage
4.
Chemosphere ; 212: 262-271, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30145418

ABSTRACT

Academics researchers and "citizen scientists" from 22 countries confirmed that yellow mealworms, the larvae of Tenebrio molitor Linnaeus, can survive by eating polystyrene (PS) foam. More detailed assessments of this capability for mealworms were carried out by12 sources: five from the USA, six from China, and one from Northern Ireland. All of these mealworms digested PS foam. PS mass decreased and depolymerization was observed, with appearance of lower molecular weight residuals and functional groups indicative of oxidative transformations in extracts from the frass (insect excrement). An addition of gentamycin (30 mg g-1), a bactericidal antibiotic, inhibited depolymerization, implicating the gut microbiome in the biodegradation process. Microbial community analyses demonstrated significant taxonomic shifts for mealworms fed diets of PS plus bran and PS alone. The results indicate that mealworms from diverse locations eat and metabolize PS and support the hypothesis that this capacity is independent of the geographic origin of the mealworms, and is likely ubiquitous to members of this species.


Subject(s)
Bacteria/metabolism , Biodegradation, Environmental , Coleoptera/metabolism , Gastrointestinal Microbiome/physiology , Larva/metabolism , Polystyrenes/metabolism , Animals , Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , China , Coleoptera/growth & development , Gastrointestinal Microbiome/drug effects , Gentamicins/pharmacology , Larva/growth & development
5.
Adv Mater ; 29(33)2017 Sep.
Article in English | MEDLINE | ID: mdl-28681930

ABSTRACT

B lymphocytes regulate several aspects of immunity including antibody production, cytokine secretion, and T-cell activation; moreover, B cell misregulation is implicated in autoimmune disorders and cancers such as multiple sclerosis and non-Hodgkin's lymphomas. The delivery of messenger RNA (mRNA) into B cells can be used to modulate and study these biological functions by means of inducing functional protein expression in a dose-dependent and time-controlled manner. However, current in vivo mRNA delivery systems fail to transfect B lymphocytes and instead primarily target hepatocytes and dendritic cells. Here, the design, synthesis, and biological evaluation of a lipid nanoparticle (LNP) system that can encapsulate mRNA, navigate to the spleen, transfect B lymphocytes, and induce more than 60 pg of protein expression per million B cells within the spleen is described. Importantly, this LNP induces more than 85% of total protein production in the spleen, despite LNPs being observed transiently in the liver and other organs. These results demonstrate that LNP composition alone can be used to modulate the site of protein induction in vivo, highlighting the critical importance of designing and synthesizing new nanomaterials for nucleic acid delivery.


Subject(s)
Lipids/chemistry , B-Lymphocytes , Liver , Nanoparticles , RNA, Messenger
6.
Adv Mater ; 28(15): 2939-43, 2016 Apr 20.
Article in English | MEDLINE | ID: mdl-26889757

ABSTRACT

Thousands of human diseases could be treated by selectively controlling the expression of specific proteins in vivo. A new series of alkenyl amino alcohol (AAA) ionizable lipid nanoparticles (LNPs) capable of delivering human mRNA with unprecedented levels of in vivo efficacy is demonstrated. This study highlights the importance of utilizing synthesis tools in tandem with biological inspiration to understand and improve nucleic acid delivery in vivo.


Subject(s)
Alkenes/chemistry , Amino Alcohols/chemistry , Biomimetic Materials/chemistry , Drug Carriers/chemistry , Lipids/chemistry , Nanoparticles/chemistry , Erythropoietin/genetics , Humans , RNA, Messenger/chemistry , RNA, Messenger/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...